novel promising agents and clinical trials in amyloidosis
Published 2 years ago • 302 plays • Length 3:01Download video MP4
Download video MP3
Similar videos
-
3:23
novel agents and clinical trials emerging for the treatment of al amyloidosis
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
9:53
key highlights in amyloidosis at ash 2023: diagnosis & novel immunotherapeutic agents being explored
-
0:52
how novel technologies and machine learning are impacting drug research in amyloidosis
-
1:14
promising novel agents in aml: menin inhibitors
-
36:35
linc 2023 - treatment of clti: new horizons with novel dcb technology
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
1:14:52
opportunity identification: discovering the "next big thing" with professor thomas lee
-
3:00
the new criteria for defining high-risk multiple myeloma
-
1:39
new clinical trial results in cardiac and peripheral nerve amyloidosis
-
6:41
clinical trials aiming to reduce the toxicity of novel agents in aml
-
1:53
novel laboratory-based therapeutic approach in al amyloidosis: investigating flc secretion
-
1:01
cll resistance mechanisms in the era of novel agents
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
1:51
thrombotic and bleeding complications in al amyloidosis
-
1:24
detection of circulating ttr aggregates: a potential novel biomarker for attr amyloidosis
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
2:20
new prognostic markers in al amyloidosis
-
1:53
discovery: cardiac amyloidosis screening study
-
2:09
integrating novel agents into the treatment of multiple myeloma